- Home
- CABA vs WSBF Comparison
CABA vs WSBF Comparison
Compare CABA & WSBF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CABA
- WSBF
- Stock Information
- Founded
- CABA 2017
- WSBF 1921
- Country
- CABA United States
- WSBF United States
- Employees
- CABA N/A
- WSBF N/A
- Industry
- CABA Biotechnology: Biological Products (No Diagnostic Substances)
- WSBF Savings Institutions
- Sector
- CABA Health Care
- WSBF Finance
- Exchange
- CABA Nasdaq
- WSBF Nasdaq
- Market Cap
- CABA 260.7M
- WSBF 273.1M
- IPO Year
- CABA 2019
- WSBF N/A
- Fundamental
- Price
- CABA $2.45
- WSBF $15.00
- Analyst Decision
- CABA Strong Buy
- WSBF
- Analyst Count
- CABA 8
- WSBF 0
- Target Price
- CABA $11.63
- WSBF N/A
- AVG Volume (30 Days)
- CABA 5.1M
- WSBF 47.5K
- Earning Date
- CABA 11-13-2025
- WSBF 10-22-2025
- Dividend Yield
- CABA N/A
- WSBF 4.00%
- EPS Growth
- CABA N/A
- WSBF 82.58
- EPS
- CABA N/A
- WSBF 1.13
- Revenue
- CABA N/A
- WSBF $134,196,000.00
- Revenue This Year
- CABA N/A
- WSBF N/A
- Revenue Next Year
- CABA N/A
- WSBF N/A
- P/E Ratio
- CABA N/A
- WSBF $13.12
- Revenue Growth
- CABA N/A
- WSBF 1.23
- 52 Week Low
- CABA $0.99
- WSBF $11.61
- 52 Week High
- CABA $5.46
- WSBF $16.86
- Technical
- Relative Strength Index (RSI)
- CABA 50.01
- WSBF 50.08
- Support Level
- CABA $2.77
- WSBF $14.62
- Resistance Level
- CABA $3.01
- WSBF $15.10
- Average True Range (ATR)
- CABA 0.37
- WSBF 0.30
- MACD
- CABA -0.03
- WSBF -0.06
- Stochastic Oscillator
- CABA 19.36
- WSBF 46.86
About CABA Cabaletta Bio Inc.
Cabaletta Bio Inc is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies and exploring their potential to provide a deep and durable, perhaps curative, treatment for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes Chimeric AutoAntibody Receptor, or CAART cells, that are designed to selectively bind and eliminate only specific B cells that produce disease-causing autoantibodies, or pathogenic B cells, while sparing normal B cells. Its CABA platform encompasses two strategies: CARTA (chimeric antigen receptor T cells for autoimmunity) and CAART (chimeric autoantibody T cells) that have the potential to be applied across a broad range of autoimmune diseases.
About WSBF Waterstone Financial Inc. (MD)
Waterstone Financial Inc is a holding company. Through its subsidiaries, it operates in two reportable segments: Community Banking and Mortgage Banking. The Community Banking segment provides consumer and business banking products and services to customers, which include various types of loans, deposits, and personal investment services. The Mortgage Banking segment involves residential mortgage loans for the primary purpose of sale in the secondary market. The vast majority of its revenue comes from the Community Banking segment.